GSK Stock - analyst views and sector context at week’s end
19.06.2026 - 21:29:34 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 21:28 CET. Details in the imprint.
GSK (GB0009252882) traded flat to slightly softer on Friday in the absence of fresh company-specific news, while large European pharma names also showed subdued moves. Existing analyst views and sector positioning therefore remained the main reference points for investors, based on current market data.
All news and background on GSK stock
Key figures, market data and the latest regulatory filings on GSK stock are bundled on the topic page and in the company’s investor-relations section.
How GSK shares closed the week
On the London Stock Exchange, GSK shares recently traded around GBP 1,925, leaving the stock roughly 15% below its 52-week high near GBP 2,282 reached in February 2026, according to current market data from the Financial Times.
Over the past 12 months the stock has gained solidly from levels near GBP 1,315 at the lower end of its 52-week range, although the recent consolidation reflects a broader pause in European pharmaceuticals after a strong run, based on available quote history.
Pharma peer group and sector sentiment
The wider European pharmaceuticals group, including names such as AstraZeneca, Sanofi and Novartis, also showed only minor price changes on Friday on the main indices, with no sector-wide catalyst reported by leading financial news services.
Against this backdrop, GSK’s valuation remains anchored by its mix of vaccines, specialty medicines and consumer-health legacy, while investors compare growth prospects and litigation risks with those of peers in the Standard & Poor's 500 index and the Stoxx Europe 600 healthcare segment where applicable.
What the company sells
GSK generates most of its revenue from prescription medicines and vaccines, including the shingles vaccine Shingrix and respiratory treatments such as Trelegy Ellipta, alongside HIV therapies through its ViiV Healthcare unit and a growing portfolio of specialty and oncology drugs.
Where the stock trades today
GSK shares (GB0009252882) trade on the London Stock Exchange at about GBP 1,925 as of 06/19/2026, 20:30 BST.
Key facts on GSK stock
- Company: GSK plc
- ISIN: GB0009252882
- WKN: 940561
- Ticker: GSK
- Venue: London Stock Exchange
- Price (as of 06/19/2026, 20:30 BST): 1,925.00 GBP
- Market cap: 80,000,000,000 GBP (as of 06/19/2026)
- Sector / Industry: Health Care - Pharmaceuticals & Biotechnology
- Index membership: FTSE 100
- Next earnings date: 07/24/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
